Perrigo Company plc Advance Royalties, Current
Perrigo Company plc (PRGO) had Advance Royalties, Current of $2.35 billion as of 2016-12-31, per its 10-K filed 2017-05-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AdvanceRoyaltiesCurrent · last filed 2017-05-23
- 2016-12-31: Advance Royalties, Current $2.35B.
- 2016-10-01: Advance Royalties, Current $3.55B.
- 2016-07-02: Advance Royalties, Current $4.02B.
- 2016-04-02: Advance Royalties, Current $5.02B.
| Period end | Advance Royalties, Current |
|---|---|
| 2016-12-31 | $2.35B 10-K · filed 2017-05-22 |
| 2016-10-01 | $3.55B 10-Q/A · filed 2017-05-23 |
| 2016-07-02 | $4.02B 10-Q/A · filed 2017-05-22 |
| 2016-04-02 | $5.02B 10-Q/A · filed 2017-05-22 |
| 2015-12-31 | $5.31B 10-Q/A · filed 2017-05-23 |
| 2015-06-27 | $5.42B 10-K · filed 2017-05-22 |
| 2014-06-28 | $5.68B 10-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |